Article
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.
Journal of psychopharmacology (Oxford, England) - 1 Oct 2012
Mitjans Marina, Gastó Cristóbal, Catalán Rosa, Fañanás Lourdes, Arias Bárbara
Abstract excerpt
First line treatment of major depression is based on selective serotonin re-uptake inhibitors (SSRIs) that enhance serotonergic neurotransmission by blocking the serotonin transporter. However, clinical response is a complex phenomenon in which other systems such as the endocannabinoid system could be involved. Given the evidence for the role of the endocannabinoid system in the pathogenesis of depression as well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
